LIG4 and thyroid gland carcinoma: Furthermore, the DNA ligase IV is detected at protein level in 50% of thyroid cancer patients (https://www.proteinatlas.org/ENSG00000174405-LIG4/pathology) thus making DNA ligase IV an attractive target to develop new antiproliferative agents.